Effect of bariatric surgery on peripheral blood lymphocyte subsets in women. 2009

Zaher O Merhi, and Helen G Durkin, and Joseph Feldman, and Jerzy Macura, and Carlos Rodriguez, and Howard Minkoff
Maimonides Medical Center, Brooklyn, New York, USA. zom00@hotmail.com

BACKGROUND The use of bariatric surgery to treat refractory obesity is increasingly common. The great weight loss that can result from these procedures has been shown to ameliorate certain deleterious effects of obesity. However, the effect of surgery on immune status is unclear. We investigated the relationship between surgical weight loss and peripheral blood lymphocyte percentages in women. METHODS Women (n=20, age range 25-59 years, body mass index [BMI] range 36.4-68.2 kg/m2) who had undergone either gastric banding (n=14) or gastric bypass (n=6) were enrolled in a prospective study to determine the percentages of their peripheral blood T cells (CD3+, CD4+, and CD8+), CD19+ B cells, and CD3-/CD16+CD56+ natural killer precursor cells before and 85+/-7 days (3 months) postoperatively using flow cytometry. The data are expressed as the percentage of total lymphocytes+/-the standard error of the mean. RESULTS A decrease in the BMI at 3 months postoperatively was 12% in the overall study population and 8% and 20% in the banding and bypass groups, respectively. No significant changes were found in the CD4+ or CD8+ T cells (P=.9 and P=.5, respectively), CD19+ B cells (P=.6), or natural killer precursor cells (P=.25) in the overall population or among the patients when stratified by surgical procedure (gastric banding or bypass). The change in CD3+ T cells approached significance (P=.06). A "same direction" (negative) correlation was found between the decrease in BMI and changes in the CD4+ T cell percentages between the pre- and postoperative levels in all the participants, and in the bypass and banding groups separately. However, it only reached statistical significance in the bypass group (r=-.96, P=.002). When studying the correlation between the decrease in BMI and the changes in CD3+ T cell percentages between the pre- and postoperative levels, a borderline significant negative correlation was found for all participants (r=-.44, P=.05) and in the bypass group (r=-.76, P=.08). The rate of change in the CD4+ and CD3+ T cells was greatest among those with the least weight loss and decreased with greater weight loss. CONCLUSIONS An inverse relationship exists between the change in certain T cells (CD4+ and CD3+) and the amount of weight lost after bariatric surgery, mainly gastric bypass surgery. The greater the decrease in BMI, the lower the change in these T cells.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009767 Obesity, Morbid The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2. Morbid Obesity,Obesity, Severe,Morbid Obesities,Obesities, Morbid,Obesities, Severe,Severe Obesities,Severe Obesity
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Zaher O Merhi, and Helen G Durkin, and Joseph Feldman, and Jerzy Macura, and Carlos Rodriguez, and Howard Minkoff
January 1987, International journal of immunopharmacology,
Zaher O Merhi, and Helen G Durkin, and Joseph Feldman, and Jerzy Macura, and Carlos Rodriguez, and Howard Minkoff
February 2015, Zhongguo shi yan xue ye xue za zhi,
Zaher O Merhi, and Helen G Durkin, and Joseph Feldman, and Jerzy Macura, and Carlos Rodriguez, and Howard Minkoff
September 1984, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
Zaher O Merhi, and Helen G Durkin, and Joseph Feldman, and Jerzy Macura, and Carlos Rodriguez, and Howard Minkoff
January 1995, Clinical rheumatology,
Zaher O Merhi, and Helen G Durkin, and Joseph Feldman, and Jerzy Macura, and Carlos Rodriguez, and Howard Minkoff
January 1987, Oncology,
Zaher O Merhi, and Helen G Durkin, and Joseph Feldman, and Jerzy Macura, and Carlos Rodriguez, and Howard Minkoff
January 1995, The American journal of Chinese medicine,
Zaher O Merhi, and Helen G Durkin, and Joseph Feldman, and Jerzy Macura, and Carlos Rodriguez, and Howard Minkoff
January 1988, Quaderni Sclavo di diagnostica clinica e di laboratorio,
Zaher O Merhi, and Helen G Durkin, and Joseph Feldman, and Jerzy Macura, and Carlos Rodriguez, and Howard Minkoff
June 2003, Transplantation proceedings,
Zaher O Merhi, and Helen G Durkin, and Joseph Feldman, and Jerzy Macura, and Carlos Rodriguez, and Howard Minkoff
May 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
Zaher O Merhi, and Helen G Durkin, and Joseph Feldman, and Jerzy Macura, and Carlos Rodriguez, and Howard Minkoff
June 1998, Sexually transmitted infections,
Copied contents to your clipboard!